Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.8.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2017
Mar. 31, 2017
Current assets    
Cash $ 920,072 $ 1,559,701
Prepaid expenses and other current assets 91,737 37,551
Total current assets 1,011,809 1,597,252
Property and equipment, net 38,858 29,223
Patents and patents pending, net 80,414 84,996
Deposits 14,897 14,897
Total assets 1,145,978 1,726,368
Current liabilties    
Accounts payable 275,579 484,423
Due to related parties 48,616 57,866
Other current liabilities 21,743 69,467
Total current liabilities 345,938 611,756
Convertible notes payable, net 780,579 519,200
Total liabilities 1,126,517 1,130,956
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of September 30, 2017 and March 31, 2017; 9,618,909 and 8,797,086 shares issued and outstanding as of September 30, 2017 and March 31, 2017, respectively 9,618 8,796
Additional paid-in capital 97,023,094 94,445,739
Accumulated deficit (96,923,845) (93,778,156)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 108,867 676,379
Noncontrolling interests (89,406) (80,967)
Total stockholders' equity 19,461 595,412
Total liabilities and stockholders' equity $ 1,145,978 $ 1,726,368